About Thiamine-responsive megaloblastic anemia syndrome
Thiamine-responsive megaloblastic anemia syndrome is a rare disease catalogued by Orphanet (ORPHA:49827). It is associated with the SLC19A2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Thiamine-responsive megaloblastic anemia syndrome trials.
Search ClinicalTrials.gov for "Thiamine-responsive megaloblastic anemia syndrome" or filter by Orphanet code ORPHA:49827 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Thiamine-responsive megaloblastic anemia syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Thiamine-responsive megaloblastic anemia syndrome. Updated daily.